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Introduction
Signal transduction initiated by receptor tyrosine kinases (RTKs) 
plays a pivotal role in the regulation of a variety of cellular 
functions, including proliferation and migration (Schlessinger, 
2000). Ligand-activated RTKs initiate such signaling in part 
by activating small GTPases, such as Ras and Rac1, a pro-
cess that is mediated by guanine nucleotide exchange factors 
(GEFs), which catalyze the exchange of GTPase-bound GDP 
for GTP (Jaffe and Hall, 2005). Son of sevenless 1 (SOS1) is 
a dual GEF for Ras and Rac1 (Nimnual et al., 1998; Nimnual 
and Bar-Sagi, 2002). SOS1 interacts with the adaptor protein 
Grb2 (Bar-Sagi, 1994). The Grb2–SOS1 complex is recruited 
to phosphotyrosine residues of ligand-activated RTKs through 
the SH2 domain of Grb2 (Bar-Sagi, 1994). RTK activation 
thus results in the translocation of SOS1 to the plasma mem-
brane, where Ras is present, thereby facilitating SOS1-mediated 
Ras activation. The Ras-specific GEF activity of SOS1 is con-
ferred by the Cdc25 domain in the central region of the protein, 
which also contains a Ras-binding region designated the Ras 
exchanger motif (REM; Bar-Sagi, 1994).
The N-terminal region of SOS1 contains a diffuse B cell 
lymphoma homology (DH) domain and a pleckstrin homology 
(PH) domain. The DH domain is responsible for Rac1-specific 
GEF activity of the protein, whereas the PH domain contributes 
to the recruitment of SOS1 to the plasma membrane (Han et al., 
1998; Nimnual et al., 1998; Das et al., 2000). SOS1 forms a 
complex with EPS8 and E3B1 (also known as Abi1) that medi-
ates Rac1 activation on the basis of its GEF activity (Innocenti 
et al., 2002). Activated Rac1 promotes actin polymerization in 
lamellipodia and cell migration (Jaffe and Hall, 2005).
CIIA was initially identified as an antiapoptotic protein   
(Cho et al., 2003; Kim et al., 2010). It was subsequently found   
to be identical to mammalian Vsp28, which plays a role in endo-
cytosis. We recently showed that CIIA promotes the epithelial– 
mesenchymal transition and cell migration (Han et al., 2009). 
We now show that CIIA is a previously unrecognized binding 
partner of SOS1. CIIA facilitates the SOS1-dependent activa-
tion of Rac1 while concomitantly repressing the SOS1-induced 
S
on of sevenless 1 (SOS1) is a dual guanine nu-
cleotide exchange factor (GEF) that activates the 
guanosine triphosphatases Rac1 and Ras, which 
mediate  signaling  initiated  by  peptide  growth  factors. 
In this paper, we show that CIIA is a new binding part-
ner of SOS1. CIIA promoted the SOS1–Rac1 interaction 
and  inhibited  the  SOS1–Ras  interaction.  Furthermore, 
CIIA promoted the formation of an SOS1–EPS8 complex 
and SOS1-mediated Rac1 activation, whereas it inhib-
ited  SOS1-mediated  activation  of  Ras.  Transforming 
growth factor  (TGF-) up-regulated the expression of 
CIIA and thereby promoted the association between CIIA 
and SOS1 in A549 human lung adenocarcinoma cells. 
Depletion of CIIA in these cells by ribonucleic acid inter-
ference inhibited the TGF-–induced interaction between 
SOS1 and EPS8, activation of Rac1, and cell migration. 
Together,  these  results  suggest  that  CIIA  mediates  the   
TGF-–induced activation of SOS1–Rac1 signaling and 
cell migration in A549 cells. They further show that CIIA 
functions as a molecular switch for the GEF activity of 
SOS1, directing this activity toward Rac1.
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that includes the DH, PH, REM, Cdc25, and proline-rich do-
mains (Fig. S1 B; Margarit et al., 2003; Sondermann et al., 
2004). The DH and PH domains contribute to the activation of 
Rac1 (Nimnual et al., 1998; Soisson et al., 1998; Nimnual and 
Bar-Sagi, 2002), whereas the REM and Cdc25 domains are 
required for Ras-specific GEF activity (Boriack-Sjodin et al., 
1998). We transfected 293T cells with a vector encoding Flag 
epitope–tagged CIIA together with a vector for Myc epitope–
tagged various fragments of SOS1 (N-terminal [SOS1-NT], 
central  [SOS1-CEN],  or  C-terminal  [SOS1-CT]  fragments). 
SOS1-NT contains the DH and PH domains, SOS1-CEN con-
tains the REM and Cdc25 domains, and SOS1-CT contains the 
proline-rich domain that includes the binding sites for Grb2 and 
E3B1 (Fig. S1 B). Coimmunoprecipitation analysis revealed 
that  CIIA-Flag  physically  associated  with  SOS1-NT  and 
SOS1-CEN as well as SOS1 but not with SOS1-CT (Fig. 1 B). 
activation of Ras. Our results suggest that CIIA functions as a 
molecular switch of SOS1, directing its GEF activity toward the 
Rac1 signaling axis.
Results and discussion
CIIA physically associates with SOS1
To provide further insight into the cellular function of CIIA, we 
searched for a CIIA-interacting protein by using a GST pull-
down assay. We detected one candidate protein (170 kD), which 
mass spectrometric analysis identified as SOS1 (Fig. S1 A). We 
confirmed the physical association between CIIA and SOS1 in 
HeLa cells by coimmunoprecipitation (Fig. 1 A). The extent of 
this association was increased by EGF treatment.
We next examined which region of SOS1 is responsible 
for its association with CIIA. SOS1 is a multidomain protein 
Figure 1.  CIIA physically interacts with SOS1. (A) HeLa cells were deprived of serum for 16 h, incubated without or with 100 ng/ml EGF for 5 min, 
lysed, and subjected to immunoprecipitation (IP) with the anti-CIIA antibody or with control preimmune IgG. The resulting precipitates as well as the lysates 
were subjected to immunoblotting (IB) with antibodies to SOS1 or CIIA. (B) 293T cells were transfected for 48 h with various combinations of expression 
vectors for the indicated proteins. Cell lysates were immunoprecipitated with the anti-Flag antibody, and the resulting precipitates were examined by   
immunoblot analysis with the anti-Myc antibody. Cell lysates were also immunoblotted with antibodies to Flag or to Myc. IgGH and IgGL indicate heavy 
and light chains, respectively, of IgG. (C and D) In vitro–translated 
35S-labeled SOS1 variants were pulled down with GST or GST-fused proteins immobi-
lized on glutathione–agarose beads. The bead-bound 
35S-labeled proteins were analyzed by SDS-PAGE and autoradiography. The gels were also stained 
with Coomassie brilliant blue. A fraction (5%) of the 
35S-labeled protein input to the binding reaction is also shown. NT, N-terminal domain; CEN, central 
domain; CT, C-terminal domain.379 Modulation of the GEF activity of SOS1 by CIIA • Hwang et al.
to bind to a GST fusion protein containing the Ras-GTP bind-
ing domain (RBD) of Raf1. EGF induced the activation of 
Ras in MDCK/control cells but not in MDCK/CIIA-Flag cells 
(Fig. 2 B). Forced expression of CIIA-Flag also inhibited the 
activation of Ras by SOS1-CEN–Myc (Fig. S2 A). The EGF-
induced activation of Erk1/2 was also apparent in MDCK/
control cells but not in MDCK/CIIA-Flag cells (Fig. 2 B). To 
investigate the role of endogenous CIIA in the activation of 
Ras and Erk1/2 signaling, we established HeLa cells stably 
expressing siRNA for CIIA or GFP (control). RNAi-mediated 
depletion of CIIA potentiated the EGF-induced activation of 
both Ras and Erk1/2 compared with that apparent in cells ex-
pressing GFP siRNA (Fig. 2 C). Similar results were obtained 
in experiments with a second CIIA siRNA whose nucleotide 
sequence did not overlap with that of the first (Fig. S2 B). 
Together, these results suggested that CIIA inhibits the EGF-
induced SOS1–Ras–Erk1/2 signaling axis.
The  central  region  of  SOS1  comprises  the  REM  and 
Cdc25 domains. The Cdc25 domain is responsible for the 
Ras-GEF catalytic activity of SOS1, whereas the REM domain 
positively regulates this activity of Cdc25 through an allosteric 
mechanism (Margarit et al., 2003). The binding of CIIA to the 
central region of SOS1 may thus be key to the molecular mech-
anism by which CIIA inhibits the interaction between SOS1 
and Ras as well as the SOS1-mediated activation of Ras. In this 
regard, it is noteworthy that CIIA inhibited the GEF activity of 
In vitro binding analysis also revealed that a GST fusion   
protein  of  CIIA  bound  to  both 
35S-labeled  SOS1-NT  and   
SOS1-CEN (Fig. 1 C). We also confirmed that GST-Ras bound to 
SOS1-CEN but not to SOS1-NT. Further in vitro binding analy-
sis revealed that the PH domain of SOS1-NT was responsible 
for the interaction with CIIA (Fig. 1 D). A separate binding 
experiment using recombinant proteins confirmed the direct 
binding of GST-CIIA to SOS1-NT and SOS1-CEN but not to 
SOS1-CT (Fig. S1 C).
CIIA inhibits the SOS1–Ras–MAPK 
signaling axis
Given that CIIA bound to SOS1-CEN, which includes the bind-
ing region for Ras (Boriack-Sjodin et al., 1998), we investigated 
whether CIIA might affect the association between SOS1 and 
Ras in MDCK cells stably expressing CIIA-Flag (MDCK/CIIA-
Flag cells) or MDCK/control cells. Coimmunoprecipitation 
analysis revealed that EGF stimulation increased the interaction 
between  SOS1  and  Ras  in  MDCK/control  cells  but  not  in 
MDCK/CIIA-Flag cells (Fig. 2 A), suggesting that CIIA indeed 
inhibits the EGF-induced association of SOS1 and Ras.
SOS1  mediates  the  EGF-induced  activation  of  Ras, 
which stimulates the Erk1/2 pathway (Buday and Downward, 
1993; Schlessinger, 2000). We therefore investigated the effect 
of CIIA on the EGF-induced activation of Ras and Erk1/2. 
Activated Ras (Ras-GTP) was detected on the basis of its ability 
Figure 2.  CIIA regulates EGF-induced Ras and Erk activation. (A) MDCK/control or MDCK/CIIA-Flag cells were deprived of serum for 16 h and incubated 
for 5 min with or without 100 ng/ml EGF. Cell lysates were immunoprecipitated (IP) with anti-SOS1 antibody, and the pellets were immunoblotted (IB) 
with anti-Ras antibody. Cell lysates were also examined directly by immunoblotting with antibodies to SOS1, Ras, or Flag. (B and C) MDCK/CIIA-Flag 
and MDCK/control cells (B) or HeLa cells stably expressing either GFP (control) or CIIA siRNA (C) were deprived of serum for 16 h and then incubated for   
5 min with or without 100 ng/ml EGF. Cell lysates were subjected to pull-down (PD) with GST-RBD and assayed for Ras activity.JCB • VOLUME 195 • NUMBER 3 • 2011   380
Collectively, these results suggested that CIIA promoted the 
activation of Rac1 by EGF.
We next examined whether CIIA might affect the physi-
cal association between SOS1 and EPS8. EGF induced the 
association of SOS1 and of EPS8 in MDCK/control cells, and 
this effect was enhanced in MDCK/CIIA-Flag cells (Fig. 4 A).   
Conversely,  silencing  of  CIIA  inhibited  the  EGF-induced   
interaction between SOS1 and EPS8 in HeLa cells (Fig. 4 B).   
These results thus suggested that CIIA promotes the inter-
action between SOS1 and EPS8. Given that E3B1 is required 
for the interaction between SOS1 and EPS8 in formation of 
the SOS1–EPS8–E3B1 tripartite complex (Scita et al., 1999), 
we examined whether CIIA exerts an E3B1-like function as 
a scaffold for SOS1 and EPS8. Indeed, CIIA physically asso-
ciated with EPS8, but not with E3B1, in transfected 293T 
cells (Fig. S3 D). Furthermore, coimmunoprecipitation analy-
sis of transfected 293T cells revealed a physical interaction 
between HA-SOS1 and EPS8-Myc only in cells coexpressing 
CIIA-Flag (Fig. 4 C). In addition, RNAi-mediated depletion of 
E3B1 abolished the EGF-induced binding between SOS1 and 
EPS8 as well as Rac1 activation in HeLa cells, whereas ectopic 
expression of CIIA in the E3B1-depleted cells restored these 
effects of EGF (Fig. 4 D). These results suggested that CIIA 
facilitates the interaction between SOS1 and EPS8 as well as 
SOS1-mediated Rac1 activation in a manner independent of 
E3B1. CIIA thus appears to function as a scaffold that sup-
ports the interaction between SOS1 and EPS8. This scaffold 
function might be an integral component of the mechanism by 
which CIIA promotes the SOS1-mediated activation of Rac1.
CIIA promotes SOS1- and Rac1-dependent 
cell migration
Rac1  mediates  EGF-induced  cell  migration  (Russell  et  al., 
2003; Katso et al., 2006; Yamaguchi et al., 2006). Indeed, a 
dominant-negative  Rac1  mutant  (Rac1N17)  markedly  inhib-
ited EGF-induced migration of HeLa cells (Fig. S3 E). RNAi- 
mediated  knockdown  of  SOS1  also  blocked  EGF-induced 
HeLa cell migration (Fig. S3 F). These results suggested that 
SOS1–Rac1 signaling mediates EGF-induced migration of 
HeLa cells. Given that CIIA facilitated SOS1-mediated Rac1 
activation (Fig. 4), we investigated the possible effect of CIIA 
on EGF-induced HeLa cell migration. The stimulatory effect 
of EGF on cell migration was markedly attenuated in cells ex-
pressing CIIA siRNA (Fig. 4 E), suggesting that CIIA facilitates 
the migration of HeLa cells dependent on the EGF–SOS1–Rac1 
signaling axis. It is also noteworthy that depletion of CIIA by 
RNAi  abrogated  the  EGF-induced  formation  of  actin-based 
membrane ruffles (Fig. 4 F).
CIIA mediates TGF-–induced cell migration
TGF- induces cell motility in various types of tumor cells 
(Massagué, 2008). Rac1 contributes in a manner that is inde-
pendent of Smad signaling to the mechanism by which TGF- 
induces such cell migration (Ng, 2008; Zhang, 2009). Indeed, 
TGF- promoted the migration of A549 human lung adeno-
carcinoma cells, and this effect was blocked either by RNAi- 
mediated depletion of SOS1 (Fig. 5 A) or by expression of the 
SOS1-CEN on Ras in vitro (Fig. S2 C). Binding of CIIA to the 
PH domain of SOS1 may also contribute to the inhibition of 
SOS1-mediated Ras activation by CIIA, given that this domain 
has been shown to modulate the Ras-GEF activity of SOS1 
(Qian et al., 1998; Zhao et al., 2007). The importance of the PH 
domain for the Ras-GEF activity of SOS1 has been also sug-
gested by the findings that mutations in the PH domain are re-
sponsible for Noonan syndrome (Roberts et al., 2006; Tartaglia 
et al., 2006).
CIIA promotes SOS1-mediated  
Rac1 activation
SOS1 physically interacts with Rac1 through its N-terminal 
region containing the DH and PH domains, resulting in Rac1 
activation (Nimnual et al., 1998). RNAi-mediated depletion 
of SOS1 suppressed the EGF-induced activation of Rac1 in 
HeLa cells (Fig. 3 A), showing that SOS1 mediates Rac1 ac-
tivation by this growth factor. Rac1 activation was detected 
by the binding of GTP-bound (active) Rac1 to a GST fusion 
protein containing the Cdc42 and Rac1 interactive binding 
(CRIB) domain of PAK1 (p21-activated kinase 1; Manser   
et al., 1994). Given that CIIA physically associated with the 
PH domain of SOS1 (Fig. 1 D), we examined the effect of 
CIIA  on  Rac1  activation  induced  by  SOS1-DHPH,  which 
possesses  the  Rac1-specific  GEF  activity.  Transfection  ex-
periments with 293T cells showed that CIIA potentiated the 
binding between Rac1 and SOS1-DHPH (Fig. S3 A) and the 
activation of Rac1 by SOS1-DHPH (Fig. 3 B). Furthermore, 
in  a  Rac1-GEF  assay,  the  fluorescence  intensity  increased 
when SOS1-DHPH was added to GST-Rac1, and this increase 
was further enhanced by CIIA (Fig. 3 C), indicating that CIIA 
increased the GEF activity of SOS1-DHPH on Rac1. Next, 
we examined the actions of CIIA variants on EGF-induced 
Rac1 activation in 239T cells that had been transfected with 
vectors for HA-SOS1 and Flag-tagged CIIA variants (CIIA, 
CIIA-C,  and  CIIA-N).  CIIA-C  and  CIIA-N  are  the 
deletion mutants of CIIA containing amino acids 1–174 and 
79–221, respectively. CIIA-C, but not CIIA-N, associated 
with SOS1 in the coimmunoprecipitation analysis (Fig. S3 B). 
CIIA  and  CIIA-C  potentiated  the  EGF-induced  stimula-
tion of Rac1 activity, whereas CIIA-N did not (Fig. S3 C).   
Additionally, CIIA and CIIA-C, but not CIIA-N, inhibited 
EGF-stimulated Ras activation (Fig. S3 C). We also showed 
that the extent of EGF-induced Rac1 activation in MDCK/CIIA-
Flag cells was markedly greater than that in MDCK/control 
cells (Fig. 3 D). Consistent with these results, RNAi-mediated 
depletion of CIIA blocked EGF-induced Rac1 activation in 
HeLa cells, and this effect was reversed by ectopic expression 
of CIIA*-Myc (Fig. 3 E), which contains three silent point 
mutations  within  the  region  targeted  by  the  CIIA  siRNA. 
This Rac1 activation by CIIA*-Myc in the cells was abro-
gated by RNAi-mediated depletion of EPS8, suggesting that 
a positive effect of CIIA on EGF-induced Rac1 activation re-
quires EPS8. Moreover, immunoblot analysis with antibodies 
to  phospho(Thr
423)-PAK1  revealed  that  the  RNAi-mediated 
knockdown of CIIA inhibited the EGF-induced activation of 
PAK1 (Fig. 3 F), a downstream target of Rac1 (Bokoch, 2003). 381 Modulation of the GEF activity of SOS1 by CIIA • Hwang et al.
Figure 3.  CIIA promotes EGF-induced SOS1–Rac1 signaling. (A) HeLa cells transfected with GFP or SOS1 siRNA for 12 h were deprived of serum for 
16 h and then incubated for 5 min with or without 100 ng/ml EGF. Cell lysates were pulled down (PD) with GST-CRIB and assayed for Rac1 activity.   
(B) 293T cells were transfected for 48 h with vectors for the indicated proteins, after which cell lysates were subjected to a pull-down assay with GST-CRIB 
as in A. (C) The GEF activity of SOS1-DHPH on Rac1 was determined in vitro in the absence or presence of CIIA by fluorescence spectroscopy with the 
use of the GEF exchange assay kit as described in Materials and methods. (top) Relative fluorescence intensity data from one representative experiment.   
(bottom) Data are the means ± SD of three independent experiments. Results are expressed as the mant-GTP incorporation into GST-Rac1 after 480 s rela-
tive to time 0 after adding His6-SOS1-DHPH. *, P < 0.05. (D) MDCK/CIIA-Flag and MDCK/control cells were deprived of serum for 16 h and incubated for   
5 min with or without 100 ng/ml EGF. Cell lysates were subjected to Rac1 activity assay as in A. (E) HeLa cells were transfected for 24 h with the indi-
cated combinations of GFP, CIIA, or E3B1 siRNA and a vector encoding CIIA*-Myc. Then, the cells were deprived of serum for 16 h and incubated for   
5 min in the presence or absence of 100 ng/ml EGF. Cell lysates were assayed for Rac1 activity as in A. (F) HeLa-siGFP or HeLa-siCIIA cells were deprived 
of serum for 16 h and then incubated for 5 min with or without 100 ng/ml EGF. Cell lysates were examined by immunoblotting (IB) with antibodies to 
phospho(Thr
423)-PAK1, PAK1, or CIIA.JCB • VOLUME 195 • NUMBER 3 • 2011   382
siRNA (Fig. 5 C). TGF- increased the expression of CIIA 
at both the mRNA and protein levels in A549 cells, and this 
effect was blocked by the IB kinase inhibitor BMS-345541   
(Fig. 5 D), suggesting that TGF- induces the expression of 
CIIA through the NF-kB signaling pathway. TGF- also increased 
dominant-negative Rac1 mutant Rac1N17 (Fig. 5 B), suggest-
ing that SOS1-Rac1 signaling mediates the stimulatory effect 
of  TGF-  on  A549  cell  migration.  Furthermore,  TGF-  in-
duced activation of Rac1 and PAK1 in A549 cells transfected 
with a control siRNA but not in those transfected with SOS1 
Figure 4.  CIIA promotes SOS1-mediated activation of Rac1. (A and B) MDCK/CIIA-Flag and MDCK/control cells (A) or HeLa cells expressing GFP 
(control) or CIIA siRNA (B) were deprived of serum for 16 h, incubated for 5 min with or without 100 ng/ml EGF, and lysed. Cell lysates were immuno-
precipitated (IP) with the anti-SOS1 antibody, and the resulting precipitates were immunoblotted (IB) with the anti-EPS8 antibody. (C) 293T cells were 
transfected for 48 h with vectors for EPS8-Myc, HA-SOS1, and CIIA-Flag as indicated. Cell lysates were immunoprecipitated with the anti-HA antibody, 
and the precipitates were immunoblotted with the anti-Myc antibody. (D) HeLa cells were transfected with either GFP or E3B1 siRNA alone or together with 
a vector encoding CIIA-Flag. After 8 h of transfection, the cells were deprived of serum for 16 h and then incubated for 5 min with or without 100 ng/ml 
EGF. Cell lysates were immunoprecipitated with the anti-SOS1 antibody, and the resulting precipitates were immunoblotted with the anti-EPS8 antibody. 
Cell lysates were also subjected to pull-down (PD) with GST-CRIB and assayed for Rac1 activity. (E) HeLa cells stably expressing GFP or CIIA siRNA were 
deprived of serum for 16 h, transferred to the upper chambers of a Transwell plate, incubated for 24 h with (black bars) or without (white bars) 100 ng/ml 
EGF in the lower chambers, and analyzed for migration. (F) HeLa cells stably expressing GFP or CIIA siRNA were serum starved for 16 h, incubated for 
5 min with (black bars) or without (white bars) 100 ng/ml EGF, and stained with Alexa Fluor red–conjugated phalloidin to detect F-actin. Arrowheads 
indicate F-actin–enriched membrane ruffles. The number of cells with ruffles were counted and expressed as the percentages relative to the total number of 
cells. Data are means ± SD from three independent experiments. *, P < 0.01. Bar, 10 µm.383 Modulation of the GEF activity of SOS1 by CIIA • Hwang et al.
Figure 5.  CIIA mediates TGF-–induced migration of A549 cells. (A, B, and G) A549 cells were transfected either with GFP (control), SOS1 (A), or CIIA 
(G) siRNA oligonucleotides or with a vector for Rac1N17 or the corresponding empty vector (B). After 8 h of transfection, the cells were deprived of serum 
for 16 h, transferred to the upper chambers of a Transwell plate, incubated for 48 h with (black bars) or without (white bars) 2 ng/ml TGF- in the lower 
chambers, and analyzed for migration. Data are means ± SD from three independent experiments. *, P < 0.01. (C) A549 cells were transfected with GFP 
or SOS1 siRNA for 16 h, deprived of serum for 10 h, and incubated with or without 2 ng/ml TGF- for 16 h. Cell lysates were then subjected to pull-down 
(PD) with GST-CRIB and assayed for Rac1 activity. (D) A549 cells were incubated with or without 10 µM BMS345541 for 1 h and then in the presence 
or absence of 2 ng/ml TGF- for 6 h (for quantitative RT-PCR analysis of CIIA mRNA) or for 16 h (for immunoblot [IB] with antibodies to CIIA or -tubulin 
[loading control]). RT-PCR data are means ± SD of triplicates from a representative experiment. (E) A549 cells were left untreated or treated with 2 ng/ml 
TGF- for 16 h, lysed, and immunoprecipitated (IP) with the anti-CIIA antibody or rabbit preimmune IgG. The resulting precipitates were immunoblotted 
with the anti-SOS1 antibody. (F) A549 cells were transfected for 12 h with GFP or CIIA siRNA oligonucleotides, deprived of serum for 16 h, and incubated 
with or without 2 ng/ml TGF- for 16 h. Cell lysates were then subjected to Rac1 activity assay as in C. Cell lysates were also immunoprecipitated with the 
anti-SOS1 antibody, and the resulting precipitates were immunoblotted with the anti-EPS8 antibody.JCB • VOLUME 195 • NUMBER 3 • 2011   384
Coimmunoprecipitation and immunoblot analysis
Cell lysates were incubated at 4°C first overnight with the appropriate anti-
bodies and then for an additional 1 h with protein G–agarose beads (GE 
Healthcare). The beads were washed three times with cell lysis buffer (Cho 
et al., 2003), and bead-bound proteins were subjected to SDS-PAGE fol-
lowed by immunoblot analysis. For immunoblot analysis, proteins were 
transferred electrophoretically from the SDS-PAGE gel to a polyvinylidene 
fluoride membrane, which was then incubated for 1 h at room temperature 
with 5% nonfat dry milk to block nonspecific sites. The membrane was 
probed with primary antibodies, washed three times, and incubated with 
horseradish peroxidase–conjugated secondary antibodies. Immune com-
plexes were visualized with the use of an enhanced chemiluminescence kit 
(SuperSignal West Pico; Thermo Fisher Scientific).
Assay for Ras and Rac1 activities
Activation of Ras and Rac1 was measured on the basis of the ability of 
the activated proteins to bind GST-RBD and GST-CRIB, respectively. GST-
RBD is a GST fusion protein containing a fragment of Raf that includes the 
binding domain for Ras-GTP (de Rooij and Bos, 1997), whereas GST-
CRIB is a GST fusion protein containing a fragment of -PAK1 that in-
cludes the CRIB region, which specifically binds GTP-bound Rac1 (Manser 
et al., 1994). Cell lysates were centrifuged at 12,000 g for 15 min at 
4°C, and the resulting soluble fraction was incubated for 2 h at 4°C with 
GST-RBD or GST-CRIB immobilized on glutathione–agarose beads. The 
bead-bound proteins were collected by centrifugation, and Ras-GTP or 
Rac1-GTP was detected by immunoblot analysis with antibodies to Ras or 
to Rac1, respectively. The intensities of bands corresponding to Ras-GTP 
or Rac1-GTP were determined by densitometry and expressed as fold in-
creases as indicated.
RNAi
HeLa cells were stably transfected with pSuper-retro vector (Oligoengine) 
encoding either an siRNA specific for human CIIA mRNA or a control 
(GFP) siRNA (Hamar et al., 2004) and named HeLa-siCIIA or HeLa-siGFP 
cells, respectively. Stable transfectants were selected in the presence of 
0.2 µg/ml puromycin. The target sequences for the CIIA and GFP siRNAs 
were 5-CCTGGGAACAAGCCGGAGCTGTATGAGGA-3 and 5-GCT-
GGAGTACAACTACAACAGCCACAACG-3, respectively. Where indi-
cated, siRNA oligonucleotides for GFP, CIIA, SOS1 (Boykevisch et al., 
2006), or E3B1 (Innocenti et al., 2004) mRNAs were obtained from   
Invitrogen and introduced into cells by transfection (electroporation) with the 
use of a microporator (Neon Transfection System; Invitrogen). The se-
quences of the siRNA oligonucleotides for human SOS1 and E3B1 were 
5-GACAGTGTTGTAATGAATT-3 and 5-ATGCATTGGCCAACAATGT-3, 
respectively. CIIA*-Myc is a Myc epitope-tagged full-length version of 
CIIA that is resistant to the CIIA siRNA as a result of three silent point mu-
tations (AAG → AAA, GAG → GAA, and TAT → TAC) within the region 
targeted by the siRNA.
Quantitative real-time RT-PCR
1 µg total RNA isolated from A549 cells with the use of a purification kit 
(RNeasy Mini; QIAGEN) was subjected to reverse transcription in a final 
volume of 20 µl with an oligo(dT) primer and Moloney murine leukemia 
virus reverse transcription (Invitrogen) as described previously (Wang et al., 
2002). Real-time PCR was performed with 5 µl of a 1:5 dilution of the 
resulting cDNA, 10 µM of each primer, and 10 µl of 2× SYBR Green Super-
mix (iQ; Bio-Rad Laboratories) in a final volume of 20 µl. The reaction was 
performed in a multicolor real-time PCR detection system (iQ5; Bio-Rad 
Laboratories), and data were analyzed with iQ5 optical system software 
(Bio-Rad Laboratories). The PCR primers (forward and reverse, respec-
tively) were 5-CAACCTCAACCGCTGCAT-3 and 5-ATGGTCTCCATC-
AGCTCTCG-3 for human CIIA and 5-GAGTCCACTGGCGTCTTCAC-3 
and 5-GTTCACACCCATGACGAACA-3 for glyceraldehyde-3-phosphate 
dehydrogenase. Reactions were performed in triplicate, and the amount of 
CIIA mRNA was normalized by the corresponding amount of glyceraldehyde-
3-phosphate dehydrogenase.
Phalloidin staining
HeLa-siGFP or HeLa-siCIIA cells seeded on glass coverslips were deprived 
of serum for 16 h, treated with 100 ng/ml EGF for 5 min where indicated, 
fixed with 3.0% formaldehyde, permeabilized in 0.1% Triton X-100, and 
then stained with Alexa Fluor red–conjugated phalloidin. Coverslips were 
mounted on a microscope slide with gold antifade reagent containing DAPI 
(ProLong; Invitrogen). F-actin images in the cells were acquired at room 
temperature with the use of a confocal microscope (LSM 510 Meta; Carl 
Zeiss) with C-Aprochromat 40×/1.2 W corr objective lens (Carl Zeiss) and 
the interaction between CIIA and SOS1 in these cells (Fig. 5 E). 
We therefore examined the possible role of CIIA in TGF-– 
induced SOS1-Rac1 signaling and cell migration in A549 
cells. RNAi-mediated depletion of CIIA inhibited the TGF-– 
induced  association  between  SOS1  and  EPS8,  activation  of 
Rac1, phosphorylation of PAK1 (Fig. 5 F), and cell migra-
tion (Fig. 5 G). Together, these results suggested that CIIA 
mediates SOS1-dependent Rac1 activation initiated by TGF- 
and that the CIIA–SOS1–Rac1 signaling axis is important for   
TGF-–induced cell migration. Given that TGF- is implicated 
in the migration and invasion of tumorigenic cells (Welch et al., 
1990; Breuhahn et al., 2006; Jakowlew, 2006; Fransvea et al., 
2008), clarification of the relations among TGF-, SOS1, and 
CIIA in tumors may provide insight into the molecular mecha-
nism of tumor progression.
Materials and methods
DNA constructs and antibodies
The  cDNAs  of  human  SOS1  variants,  including  the  full-length  protein, 
SOS1-NT  (amino  acid  residues  1–550),  histone-fold  domain  of  SOS1 
(SOS1-HF; residues 1–198), SOS1-DH (residues 199–404), SOS1-PH (res-
idues 442–550), SOS1-DHPH (residues 199–550), SOS1-CEN (residues 
551–1,050), and SOS1-CT (residues 1,051–1,333), were generated by   
PCR with pMT2-HA-hSOS1 (provided by P.P. Di Fiore, University of Milan, 
Milan, Italy) as a template and were inserted into pcDNA6-His-Myc-A 
vector (Invitrogen). Mouse CIIA cDNA was inserted into pcDNA6-Myc-A 
or pcDNA3-puro for expression of Myc epitope–tagged or Flag-tagged 
proteins, respectively. An expression vector for Myc-tagged Rac1N17 was 
provided by A. Hall (Memorial Sloan-Kettering Cancer Center, New York, 
NY). A bacterial expression vector encoding a GST fusion protein of CRIB 
was constructed by subcloning cDNA corresponding to the CRIB region 
of rat -PAK1 into pGEX-4T2. A pGEX-2T vector encoding GST-fused RBD 
of Raf1 was provided by C. Herrmann (Ruhr University Bochum, Bochum, 
Germany). Vectors encoding Myc-tagged human E3B1 (pcDNA3-E3B1-
Myc) and Myc-tagged human EPS8 (pCR-Myc-EPS8) were provided by 
D. Park (Seoul National University, Seoul, Korea) and G. Scita (Universitá 
degli Studi di Milano, Milan, Italy), respectively.
Rabbit polyclonal antibodies to CIIA, SOS1, and EPS8 were ob-
tained from Santa Cruz Biotechnology, Inc. Rabbit polyclonal antibodies to 
CIIA were purchased from LabFrontier, and those to E3B1 (Abi1) were 
purchased from Sigma-Aldrich. Mouse monoclonal antibodies to Ras and 
Rac1 were obtained from BD, and those to the HA epitope and Flag were 
obtained  from  Sigma-Aldrich.  Rabbit  polyclonal  antibodies  to  Erk1/2, 
phosphorylated  Erk1/2,  PAK1,  and  phosphorylated  PAK1  as  well  as 
mouse monoclonal antibodies to the Myc epitope were obtained from Cell 
Signaling Technology.
Cell culture and DNA transfection
Human embryonic kidney 293T, MDCK, HeLa, and A549 cells were 
routinely maintained under a humidified atmosphere of 5% CO2 at 37°C 
in  DME  (Hyclone)  supplemented  with  10%  heat-inactivated  FBS.  Cul-
tured cells were transfected with expression vectors either by the calcium 
phosphate method or with the use of Lipofectamine (Invitrogen). For stable 
transfection of MDCK cells, the cells were transfected with pcDNA3-
puro-CIIA-Flag or with the empty vector (pcDNA3-puro), and puromycin- 
resistant cells were selected in complete medium containing 1.7 µg/ml 
puromycin. MDCK cells stably expressing CIIA-Flag and the correspond-
ing control cells were named as MDCK/CIIA-Flag and MDCK/control 
cells, respectively.
In vitro binding assay
35S-labeled SOS1 and deletion mutants thereof were produced in vitro 
with the use of the reticulocyte lysate system (TnT; Promega). The 
35S- 
labeled proteins were incubated at 4°C for 2 h in a binding buffer (Cho   
et al., 2003) with GST alone or GST fusion proteins immobilized on   
glutathione–agarose  beads.  The  beads  were  then  washed,  and  bead-
bound 
35S-labeled proteins were separated by SDS-PAGE and analyzed 
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a 2× zoom in magnification. Data were acquired with LSM Image Examiner 
software (Carl Zeiss) and imported into Photoshop (Adobe).
In vitro GEF assay
Recombinant  proteins  of  His6-SOS1-DHPH,  His6-SOS1-CEN,  His6-CIIA, 
GST-Rac1, and GST-Ras were expressed in and purified from Escherichia 
coli. In vitro GEF assays were performed with the use of a GEF exchange 
assay (Biochem Kit; Cytoskeleton) according to the manufacturer’s proto-
col. In brief, N-methylanthraniloyl (mant)–GTP incorporation into GST-Rac1 
or GST-Ras was analyzed by fluorescence spectroscopy with the use of a 
multilabel plate reader (fluorescence/luminescence; Victor3; PerkinElmer). 
Either 0.2 µg GST-Rac1 or 0.2 µg GST-Ras was added without or with   
0.2 µg His6-CIIA in 15 µl reaction buffer containing 20 mM Tris, pH 7.5, 
50 mM NaCl, 10 mM MgCl2, 50 µg/ml BSA, and 0.75 µM mant-GTP. 
The exchange reaction mixtures were placed into a 384-well black-colored 
plate (Corning), and the fluorescence of each sample was measured at 
20°C every 30 s with excitation and emission wavelengths of 360 and 
440 nm, respectively. After 150 s, the exchange reaction was initiated by 
adding His6-SOS1-DHPH or His6-SOS1-CEN into the Rac1 or Ras reaction 
mixtures, respectively, and the relative mant fluorescence was monitored 
for 55 readings.
Cell migration assay
For Transwell migration assays, 10
4 cells were deprived of serum for 16 h 
and then added in 0.2 ml culture medium containing 0.1% (instead of 
10%) FBS to the upper chambers of a 24-well Transwell plate (pore size of 
8 µm; Corning). The lower chambers of the plate were loaded with 0.6 ml 
of the same medium. Where indicated, 100 ng/ml EGF or 2 ng/ml TGF- 
was added to the lower chambers. After incubation with EGF for 24 h or 
with TGF- for 48 h, cells on the upper surface of each membrane were   
removed by scraping with a cotton swab. Motile cells on the underside of 
the membrane were fixed and stained with a stain kit (Diff Quik; Sysmex). 
For each experiment, the stained cells in three random fields on the under-
side of the membrane were quantified by light microscopy (40× objective). 
Data are means ± SD of values from three independent experiments.
Statistical analysis
Data are presented as means ± SD and were analyzed by analysis of vari-
ance. P < 0.05 was considered statistically significant.
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Fig. S1 shows the identification of SOS1 as a CIIA-binding protein. Fig. S2 
shows that CIIA inhibits the SOS1-mediated activation of Ras. Fig. S3 
shows that CIIA promotes the binding of Rac1 to SOS1-DHPH and that a 
dominant-negative Rac1 mutant Rac1N17 inhibits EGF-induced migration 
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.jcb.org/cgi/content/full/jcb.201106138/DC1.
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